Clarification regarding coverage of diagnostic procedures to test for infertility and fertility-enhancing drugs.

Changes to the transmittal since the original publication include:

• The table outlining covered drugs has been removed, as it was the main source of confusion among MCPs.
• The transmittal text now explicitly highlights the newly covered class of drugs resulting from the SPA approval.